



The immune response to infection
depends centrally on the T
lymphocytes of the immune system,
and the detection of infection by T
lymphocytes depends in turn on the
presentation of antigen to the T cells
by molecules encoded in the major
histocompatibility complex (MHC).
The biological function of these
molecules is to bind proteolytic
fragments (peptides) derived from
foreign proteins generated inside
cells either from intracellular
parasites such as viruses, or from
microorganisms or toxins internalized
by cells, and display them on the cell
surface where the complex of MHC
molecule and peptide can be
recognized by T cells.
There are three points in the life
of a T cell at which the recognition
of an MHC–peptide complex has a
pivotal effect: the first is when the
repertoire of T-cell antigen receptors
is selected during the maturation of
T lymphocytes in the thymus; the
second is at the initiation of an
immune response in the lymph node,
where specialized antigen-presenting
cells activate the proliferation of
antigen-specific T cells and their
differentiation into effector cells; and
the third is at the final encounter of
the effector T cell with its target.
The basic cell biology of antigen
presentation is now broadly
understood, and the focus of interest
is shifting to modulations of the basic
process that may answer broader
biological questions about how the
T-cell repertoire is selected in the
thymus and modified by specialized
antigen-presenting cells in the lymph
nodes. It has also become clear that
viruses have evolved a remarkable
arsenal of devices for interfering with
the formation of peptide–MHC
complexes and their migration to the
cell surface, and thereby avoiding
detection by T cells.
The detection of infection
There are two types of MHC
molecule and two pathways of
antigen processing and presentation.
Broadly speaking, MHC class I
molecules bind and display peptides
derived from intracellular parasites
(notably viruses) proliferating in the
cytoplasm, whereas MHC class II
molecules bind and display peptides
derived from extracellular
microorganisms and their products
which have been internalized and
degraded in the vesicular
compartments of cells. The
peptide-loaded MHC molecules that
appear on the cell surface are then
differentially recognized by the two
major classes of T cell: MHC class I
molecules are recognized by
cytotoxic T cells, which directly
destroy cells infected with viruses,
whereas MHC class II molecules are
recognized by helper T cells, which
generally act indirectly by activating
B lymphocytes to produce antibodies
and macrophages to destroy bacteria,
and are thought to be necessary for
effective cytotoxic T lymphocyte
responses to cells harbouring viruses. 
The main structural features of
the two classes of MHC molecule are
illustrated in Figure 1. The two most
distinctive characteristics of MHC
molecules, shared by both classes, are
their extraordinary polymorphism and
the peptide-binding cleft formed by
their membrane-distal domains, in
which the polymorphic amino acids
are concentrated. The polymorphism
of the peptide-binding domains, and
the co-expression of MHC molecules
from more than one gene, enable the
MHC molecules of any given
individual to bind a wide range of
peptides where they can be efficiently
recognized by the highly variable
antigen receptors of T lymphocytes.
The differential recognition of
MHC class I molecules by the
antigen receptors of cytotoxic T cells,
and of MHC class II molecules by
those of helper T cells, is promoted
by the co-receptors CD8 and CD4
which are expressed on T cells and
recognize nonpolymorphic
determinants of MHC class I
molecules and MHC class II
molecules respectively. CD4 and
CD8 were originally identified as
markers for T cells of distinct
functional classes and purists refer to
CD4 and CD8 T cells, not helper
and cytotoxic cells.
The distinct roles of the two
classes of MHC molecule are
reflected in their tissue distribution.
MHC class I molecules are required
to flag viral infection and because
almost any cell can be infected with
a virus, all nucleated cells express
MHC class I molecules. MHC class
II molecules, by contrast, are
important chiefly in communication
between cells of the immune system
— for example, the display of
internalized antigen to T cells by
specialized antigen-presenting cells
at the initiation of an immune
response, or by the B cells and
macrophages that are activated by
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Figure 1
The structure of MHC molecules. The MHC
class I and MHC class II molecules are
structurally homologous, each having two
immunoglobulin-like membrane-proximal
domains and two membrane-distal domains
that form a peptide-binding cleft. But
whereas the α and β chains of the MHC
class II molecule contain one
membrane-proximal and one distal domain
each and are both encoded in the MHC, the
MHC class I α chain contains both
membrane-distal domains and the β chain,
β2-microglobulin (β2-m), is encoded outside
the MHC on a separate chromosome. Three
different genes encode polymorphic α
chains of the MHC class I molecule and
there are also several genes encoding each
of the polymorphic α and β chains of the
MHC class II molecules; β2-microglobulin is
not polymorphic.
MHC class I MHC class II
α chain β chain
β2-m




effector T cells — and their
expression is limited to cells that are
important in the initiation and
activation of immune responses.
Logistics of peptide loading
Both MHC class I molecules and
MHC class II molecules, like all
other plasma membrane proteins, are
synthesized with their extracellular
domains extending into the lumen of
the endoplasmic reticulum (ER), and
this raises logistic questions about
how each type of MHC molecule is
efficiently loaded with a peptide
cargo from the appropriate
intracellular compartment on its way
to the cell surface. In the case of the
class I MHC molecules, peptides
derived from viral proteins
synthesized in the cytosol must find
their way into the lumen of the ER.
MHC class II molecules, by contrast,
must avoid binding proteins present
in the lumen of the ER and be
diverted from the normal route to the
cell surface into a pathway that
intersects with that of the endocytic
vesicles containing internalized
proteins (see Figure 2). For both
classes of MHC molecule, the
presence of bound peptide is
necessary for the stable folding of the
protein, and peptide loading — like
protein folding — is a chaperoned
process (see Figure 2).
The chaperoning of peptide
loading has become known
somewhat confusingly as peptide
editing, the editorial function being
the selection of peptides that bind
stably to the MHC molecule. By
releasing only stably folded
complexes of MHC molecule and
peptide, the chaperones are thought
to ensure that MHC–peptide
complexes with short half-lives rarely
reach the cell surface; this is
important because the induction of
T-cell responses requires sustained
display of the antigenic peptide on
the presenting cell. 
How do MHC molecules avoid
displaying self peptides? The answer is
that they don’t. The peptide-binding
clefts of most MHC molecules are
filled with self peptides but these
complexes are ignored by T cells
because those cells bearing receptors
that recognize self peptides are
eliminated during T-cell maturation
in the thymus — a process called
negative selection. Paradoxically,
immature T cells are also positively
selected in the thymus for
recognition of self MHC plus foreign
peptides, by a process that is still not
understood. Differential peptide
editing by thymic cells has attracted
attention as a possible mechanism.
Selection of T cells in the thymus
During their maturation in the
thymus, immature T cells
(thymocytes) migrate through the
thymic cortex to exit through the
medulla. Positive selection is
believed to occur at the surface of
thymic epithelial cells in the cortex,
and negative selection of potentially
self-reactive cells at the surface of
various cell types but particularly
that of dendritic cells. Dendritic cells
are concentrated at the junction of
the thymic cortex and the medulla
and are the most important and
potent of the three types of
specialized antigen-presenting cell
responsible for the initiation of
immune responses in response to
infection (the other two are
macrophages and B cells).
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Figure 2
Antigen processing and presentation
pathways. Both MHC class I (yellow) and
MHC class II (purple) molecules are
synthesized with their extracellular domains
projecting into the lumen of the
endoplasmic reticulum (ER). The MHC
class II molecule is prevented from binding
peptides in the ER lumen by the invariant
chain (blue) which binds to it and blocks the
peptide-binding cleft. Instead of following
the normal secretory pathway to the cell
surface, MHC class II molecules are routed
by the invariant chain into acidic endosomes
containing internalized proteins from the cell
exterior. In the endosomes, the invariant
chain is degraded, leaving only a fragment,
CLIP, still protecting the peptide-binding
cleft. This is degraded and released when
the MHC class II molecule binds to the
chaperone DM (accompanied in some cells
by DO, not shown here). The MHC class II
molecule can then bind peptides derived
from internalized proteins degraded in the
endosome, is released from DM and
proceeds to the cell surface. Newly
synthesized MHC class I α chains bind
successively to three chaperones (orange).
The first is calnexin, which is replaced by
calreticulin after β2-microglobulin is bound.
Calreticulin and the MHC class I molecule
then form a complex with tapasin, which
binds the TAP transporter through which
peptides generated by the degradation of
proteins by proteasomes in the cytoplasm are
transported into the lumen of the ER. Once
peptide is bound, the MHC class I molecule
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Clearly, the T-cell receptor
specificities that are positively
selected on the thymic epithelium
must be distinct from those that are
subsequently eliminated by
dendritic cells otherwise no T cells
would ever emerge from the thymus.
Two main possibilities have been
suggested to account for this
difference. One is that the strength
of the signal to the thymocytes varies
between the thymic cortex and the
medulla — because the density of
antigen presented is different, or
because of changes in the sensitivity
of the developing thymocytes, or
both. The other is that a different
array of peptides is presented on
cortical and medullary cells. This
could in principle be achieved by
differential peptide editing.
No definitive statement is at
present possible on the mechanism
of thymic selection, and a discussion
of the evidence would require an
article to itself. But two possibilities
that have recently been considered
as the basis for differential peptide
editing are the enzymes that cleave
the invariant chain, and the
chaperones that regulate the loading
of peptide in the acidic endosomes.
Thus, for example, in thymic
epithelial cells the invariant chain is
cleaved by the endosomal protease
cathepsin L, whereas in dendritic
cells it is cleaved by a different
member of the same enzyme family,
cathepsin S. Although there is
evidence that this does indeed result
in the display of a different range of
peptides on these two classes of cell,
evidence for physiological effects on
thymic selection is so far ambiguous.
A second recent focus of
speculation is the nonpolymorphic
MHC class II molecule DO. DO
binds the chaperone DM,
influencing its peptide editing
function, and is expressed in B cells,
thymic epithelium and possibly
dendritic cells. All three of these cell
types influence the T-cell repertoire:
thymic epithelium and dendritic
cells exercise positive and negative
selection in the thymus, and B cells
are thought to induce tolerance in
the periphery to self peptides not
encountered on thymic cells. On the
basis of evidence that DO acts as an
inhibitor of DM, it has been
suggested that it may indiscriminately
broaden the range of peptides
allowed to reach the cell surface,
thereby affecting selection of the 
T-cell repertoire in the thymus and
the periphery (see Curr Biol 1998,
8:R128–R131). At this stage, however,
the physiological action of DO is not
clear, and it may operate as a
co-chaperone with DM rather than as
an inhibitor.
The best, therefore, that can be
said about the contribution of recent
research on antigen processing to 
the thymic selection problem is 
that it has suggested more avenues
for exploration.
Sabotage strategies
The recognition of an increasing
number of components of antigen-
presentation pathways has recently
been paralleled by the identification
of an increasing repertoire of viral
proteins that seem to have evolved
for the express purpose of disabling
them. The related chronic viruses
cytomegalovirus, herpes simplex
virus and Epstein–Barr virus, and
more recently human
immunodeficiency virus (HIV), seem
to have converged on a number of
devices for preventing, or at least
delaying, their own detection.
The virus with the largest range
of sabotage devices known so far is
cytomegalovirus, a cause of
respiratory disease particularly in
immunocompromised individuals in
whom it can be fatal.
Cytomegalovirus blocks the
up-regulation of MHC class II
molecules by cytokines and disrupts
peptide display by MHC class I
molecules at four different points.
One viral protein, pp65, interferes
with proteolysis in the cytoplasm
and inhibits the generation of
antigenic peptides; a second, US6,
binds to the TAP transporter and
depresses peptide transport; a third,
US3, binds to the MHC class I
molecule and retains it in the ER by
means of an ER retrieval signal in its
tail; and two other proteins, US2 and
US11, seem to reverse the protein
translocation apparatus whereby
membrane and secreted proteins are
extruded into the lumen of the ER,
so that MHC class I molecules are
instead expelled into the cytoplasm
whence they have no means of
reaching the cell surface. The other
chronic viruses also encode proteins
that interfere with one or more of
these processes.
Most recently, the Vpu and Nef
proteins encoded by HIV have been
implicated in the down-regulation of
MHC class I expression in
HIV-infected cells, Vpu by
detaining the class I molecules in
the ER and Nef by directing surface
MHC class I molecules into coated
pits through which they are
internalized, routed into the
lysosomal pathway and destroyed.
The hazard to the virus of down-
regulating MHC class I expression is
that it thereby exposes itself to
attack by natural killer cells which
are programmed to destroy cells in
the absence of surface MHC class I
(see Curr Biol 1998, 8:R595–R597);
but cytomegalovirus has outflanked
even this default defence option, by
evolving an MHC class I surrogate
as a decoy.
It is a measure of the importance
of antigen presentation to T cells
that so many viral strategies have
evolved in parallel to confound it.
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